Document is current
Any future updates will be listed below
-
Authors
Ludbrook, Valerie J. https://orcid.org/0000-0003-3315-9758
Budd, David C.
Thorn, Katie
Tompson, Debra
Votta, Bartholomew J.
Walker, Lucy
Lee, Amy
Chen, Xin
Peppercorn, Amanda
Loo, Wei Jing
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 5 January 2024
First Online: 19 February 2024
Declarations
:
: Valerie J. Ludbrook, David C. Budd, Katie Thorn, Debra Tompson, Bartholomew J. Votta, Lucy Walker, Amy Lee, Xin Chen, and Amanda Peppercorn are employees of and stockholders in GSK. Wei Jing Loo has served as an investigator, speaker, advisor/consultant for and/or received grants/honoraria from AbbVie, Amgen, Arcutis, Bausch Health, BMS, Celgene, Eli Lilly, Galderma, GSK, Janssen, LEO Pharma, Meiji Seika Pharma, Pediapharm, Novartis, Pfizer, Sanofi Genzyme, Sun Pharma, UCB, and Valeant, and she and her institution received funding for this study from GSK.
: The study was approved by the main ethics committee, Institutional Review Board Services Advarra, Ontario Canada every participating institution and was conducted according to the recommendations of Good Clinical Practice and the Declaration of Helsinki. The study protocol, amendments, informed consent, and other information requiring preapproval were reviewed and approved by an institutional review board. All patients provided written informed consent to participate in the study.
